| Code | 7999C | ||||||||||
| MA number | 78/0175/18-S | ||||||||||
| Product Form: | cps dur 14x18 mg (blis.PA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 78 - SYMPATHOMIMETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.05.2018 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Atofab 18 mg_cps dur_05/2018_REG.doc
|
| PIL: |
PIL_Atofab_cps dur_07_2022.pdf
|
| Safety feature | Yes |
| Data update: | 23.11.2022 |
